Breast microcalcifications and their role in breast cancer bone metastasis

乳腺微钙化及其在乳腺癌骨转移中的作用

基本信息

  • 批准号:
    8551656
  • 负责人:
  • 金额:
    $ 31.48万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-09-26 至 2017-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Breast cancer frequently metastasizes to bone where it leads to osteolysis and poor clinical prognosis; however, the underlying roles of hydroxyapatite (HA) - a key component of breast microcalcifications (i.e., a negative prognostic factor for breast cancer) and the bone mineral matrix - remain unclear in this process, due in part to a lack of appropriate model systems. In the presence of a tumor, the physicochemical properties of HA (e.g., crystallinity, chemical composition, size, and aspect ratio) vary with disease state at both the primary (breast) and secondary (bone) sites. The overall hypothesis guiding the current investigator is: tumor-mediated changes to HA materials properties enhance breast cancer metastasis to bone by inducing a bone-metastatic phenotype at the primary site. These cells, in turn, promote premetastatic bone remodeling, which ultimately fosters bone colonization. We have previously developed mineral-containing 3-D tumor models, which permit testing of the importance of the physicochemical properties of HA in breast cancer spreading to bone. Using this system, coupled with advanced materials characterization techniques, we will test three subhypotheses: 1) HA in microcalcifications associated with more aggressive breast cancer is characterized by increased size and crystallinity and leads to the up-regulation of bone metastatic properties in breast cancer cells due in part to varied non-specific protein adsorption; 2) HA in the bones of tumor-bearing mice is characterized by decreased size and crystallinity even prior to metastatic colonization. These changes favor tumor cell seeding and growth, which are mediated by tumor-secreted endocrine signals that differentially regulate bone cell behavior; 3) Increased bone-metastatic potential of breast cancer cells due to interactions with HA enhances premetastatic bone remodeling, which, in turn, increases the osteotropism of breast cancer cells; pharmacological intervention with this process can decrease bone metastasis. There are three specific aims designed to test these hypotheses: In Aim 1, we will characterize HA materials properties in breast microcalcifications, and assess their impact on the bone-metastatic potential of tumor cells. In Aim 2, we will characterize HA materials properties in the bones of tumor-bearing animals pre- and post-colonization with breast cancer cells, and identify their role in secondary tumor formation. In Aim 3, we will assess the integrated effects of breast microcalcifications and premetastatic bone remodeling on breast cancer bone metastasis. The novel combination of cancer biology with engineering and materials science approaches will result in a highly reproducible and pathologically relevant culture platform that will allow us to deconvolute the complexity of bone metastasis and identify molecular targets for improved therapies. By elucidating the importance of materials-based mechanisms, the proposed research has the potential to challenge the currently accepted paradigm of bone metastasis as a disease that is solely mediated by cellular and molecular changes.
描述(由申请人提供):乳腺癌经常转移到骨,导致骨质溶解和临床预后不良;然而,羟基磷灰石(HA)的潜在作用-乳腺微钙化的关键成分(即,乳腺癌的负面预后因素)和骨矿物质基质-在这一过程中仍然不清楚,部分原因是缺乏适当的模型系统。在存在肿瘤的情况下,HA的物理化学性质(例如,结晶度、化学组成、尺寸和纵横比)在原发性(乳房)和继发性(骨)部位随疾病状态而变化。指导当前研究者的总体假设是:肿瘤介导的HA材料特性变化通过在原发部位诱导骨转移表型来增强乳腺癌骨转移。反过来,这些细胞促进转移前骨重建,最终促进骨定植。我们以前已经开发了含矿物质的3-D肿瘤模型,它允许测试的重要性,在乳腺癌扩散到骨的HA的物理化学性质。使用该系统,结合先进的材料表征技术,我们将测试三个子假设:1)与更具侵袭性的乳腺癌相关的微钙化中的HA的特征在于尺寸和结晶度增加,并导致乳腺癌细胞中骨转移特性的上调,部分原因是不同的非特异性蛋白质吸附; 2)荷瘤小鼠骨中的HA的特征在于甚至在转移性定殖之前减小的尺寸和结晶度。这些变化有利于肿瘤细胞的接种和生长,这是由肿瘤分泌的内分泌信号介导的,差异调节骨细胞的行为; 3)由于与HA的相互作用,增加了乳腺癌细胞的骨转移潜力,增强了转移前骨重建,这反过来又增加了乳腺癌细胞的向骨性;对这一过程的药物干预可以减少骨转移。有三个特定的目标旨在测试这些假设:在目标1中,我们将表征乳腺微钙化中的HA材料特性,并评估其对肿瘤细胞骨转移潜力的影响。在目标2中,我们将表征乳腺癌细胞定植前和定植后荷瘤动物骨骼中的HA材料特性,并确定其在继发性肿瘤形成中的作用。在目标3中,我们将评估乳腺微钙化和转移前骨重建对乳腺癌骨转移的综合影响。癌症生物学与工程和材料科学方法的新组合将产生高度可重复和病理相关的培养平台,使我们能够解卷积骨转移的复杂性,并确定改进治疗的分子靶点。通过阐明基于材料的机制的重要性,拟议的研究有可能挑战目前公认的骨转移作为一种仅由细胞和分子变化介导的疾病的范式。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Claudia Fischbach其他文献

Claudia Fischbach的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Claudia Fischbach', 18)}}的其他基金

Mechanical properties of adipose tissue and its effect on breast cancer
脂肪组织的力学特性及其对乳腺癌的影响
  • 批准号:
    10737165
  • 财政年份:
    2023
  • 资助金额:
    $ 31.48万
  • 项目类别:
(PQA2) Interstitial stiffness as a physicochemical modulator of obesity-induced b
(PQA2) 间质硬度作为肥胖引起的 b 的理化调节剂
  • 批准号:
    8687164
  • 财政年份:
    2014
  • 资助金额:
    $ 31.48万
  • 项目类别:
Breast microcalcifications and their role in breast cancer bone metastasis
乳腺微钙化及其在乳腺癌骨转移中的作用
  • 批准号:
    8706099
  • 财政年份:
    2012
  • 资助金额:
    $ 31.48万
  • 项目类别:
Breast microcalcifications and their role in breast cancer bone metastasis
乳腺微钙化及其在乳腺癌骨转移中的作用
  • 批准号:
    9114092
  • 财政年份:
    2012
  • 资助金额:
    $ 31.48万
  • 项目类别:
Breast microcalcifications and their role in breast cancer bone metastasis
乳腺微钙化及其在乳腺癌骨转移中的作用
  • 批准号:
    8421316
  • 财政年份:
    2012
  • 资助金额:
    $ 31.48万
  • 项目类别:
Fibronectin and its role in tumor stiffness and vascularization
纤连蛋白及其在肿瘤硬度和血管化中的作用
  • 批准号:
    8308649
  • 财政年份:
    2011
  • 资助金额:
    $ 31.48万
  • 项目类别:
Fibronectin and its role in tumor stiffness and vascularization
纤连蛋白及其在肿瘤硬度和血管化中的作用
  • 批准号:
    8176810
  • 财政年份:
    2011
  • 资助金额:
    $ 31.48万
  • 项目类别:
Physicochemical Cues and Their Roles in the Angiogenic Switch
物理化学线索及其在血管生成开关中的作用
  • 批准号:
    7796233
  • 财政年份:
    2010
  • 资助金额:
    $ 31.48万
  • 项目类别:
Microfluidic tumor models to analyze the role of physicochemical cues in the angi
微流控肿瘤模型分析理化信号在血管生成中的作用
  • 批准号:
    7828797
  • 财政年份:
    2009
  • 资助金额:
    $ 31.48万
  • 项目类别:
Microfluidic tumor models to analyze the role of physicochemical cues in the angi
微流控肿瘤模型分析理化信号在血管生成中的作用
  • 批准号:
    7943105
  • 财政年份:
    2009
  • 资助金额:
    $ 31.48万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 31.48万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.48万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 31.48万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.48万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 31.48万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 31.48万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.48万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 31.48万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 31.48万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.48万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了